lipoxin a4 has been researched along with Fibrosis in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Anfossi, R; Catalán, M; Díaz-Araya, G; González-Herrera, F; Gutiérrez-Figueroa, R; Maya, JD; Vivar, R | 1 |
Cho, J; Han, SY; Kim, H; Kim, JM; Lee, YS; Park, SH | 1 |
Bai, Y; He, Z; Jiang, H; Li, L; Wang, J; Yang, M | 1 |
Ali-Shah, ST; Börgeson, E; Brennan, EP; Docherty, NG; Godson, C; Gough, OS; Guiry, PJ; Higgins, DF; Martin, F; Maxwell, AP; McEvoy, CM; Murphy, M; Nolan, KA; Sadlier, DM; Savage, DA | 1 |
Börgeson, E; Docherty, NG; Godson, C; Goldschmeding, R; Guiry, PJ; Higgins, DF; Murphy, M; O'Sullivan, TP; Rodgers, K; Ryan, A | 1 |
Akhmetshina, A; Dees, C; Distler, JH; Distler, O; Krönke, G; Lang, V; Palumbo, K; Reich, N; Schett, G; Scholtysek, C; Uderhardt, S; Zerr, P | 1 |
Godson, C; McMahon, B; Mitchell, D; Rodgers, K; Sadlier, D | 1 |
7 other study(ies) available for lipoxin a4 and Fibrosis
Article | Year |
---|---|
Lipoxin A4 prevents high glucose-induced inflammatory response in cardiac fibroblast through FOXO1 inhibition.
Topics: Fibroblasts; Fibrosis; Forkhead Box Protein O1; Glucose; Humans; Inflammation; Lipoxins; NF-kappa B | 2023 |
LXA
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Fibrosis; Humans; Lipoxins; Lung; Male; Mice; Mice, Inbred C57BL; Pulmonary Fibrosis; Radiation; Radiotherapy; Receptor Cross-Talk; Receptors, Formyl Peptide; Receptors, Lipoxin; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2020 |
Mesenchymal Stem Cells Reverse Diabetic Nephropathy Disease via Lipoxin A4 by Targeting Transforming Growth Factor β (TGF-β)/smad Pathway and Pro-Inflammatory Cytokines.
Topics: Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Docosahexaenoic Acids; Fibrosis; Inflammation Mediators; Lipoxins; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rats; Rats, Sprague-Dawley; Signal Transduction; Smad Proteins; Transforming Growth Factor beta | 2019 |
Lipoxins attenuate renal fibrosis by inducing let-7c and suppressing TGFβR1.
Topics: Cadherins; Cells, Cultured; Fibronectins; Fibrosis; Humans; Kidney; Kidney Tubules, Proximal; Lipoxins; MicroRNAs; Receptor, Notch1; Signal Transduction; Thrombospondins; Transforming Growth Factor beta1 | 2013 |
Lipoxin A₄ and benzo-lipoxin A₄ attenuate experimental renal fibrosis.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Collagen; Disease Models, Animal; Fibrosis; Gene Expression Regulation; Kidney; Kidney Diseases; Ligation; Lipoxins; Male; Rats; Rats, Wistar; Transforming Growth Factor beta1 | 2011 |
The 12/15-lipoxygenase pathway counteracts fibroblast activation and experimental fibrosis.
Topics: Animals; Antibiotics, Antineoplastic; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Bleomycin; Cells, Cultured; Dermis; Eicosanoids; Fibroblasts; Fibrosis; Lipoxins; Mesoderm; Mice; Mice, Inbred C57BL; Mice, Knockout; Phenotype; Protein Serine-Threonine Kinases; Scleroderma, Systemic; Transforming Growth Factor beta | 2012 |
Lipoxin A4 modifies platelet-derived growth factor-induced pro-fibrotic gene expression in human renal mesangial cells.
Topics: Cell Differentiation; Cell Extracts; Cells, Cultured; Epithelial Cells; Fibrosis; Gene Expression; Glomerular Mesangium; Humans; Kidney Tubules, Proximal; Lipoxins; Mesoderm; Oligonucleotide Array Sequence Analysis; Platelet-Derived Growth Factor | 2005 |